Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice

Infect Immun. 2000 May;68(5):2837-44. doi: 10.1128/IAI.68.5.2837-2844.2000.

Abstract

Interleukin-10 (IL-10) is associated with inhibition of cell-mediated immunity and downregulation of the expression of costimulatory molecules required for T-cell activation. When IL-10-deficient (IL-10KO) mice are infected with Toxoplasma gondii, they succumb to a T-cell-mediated shock-like reaction characterized by the overproduction of IL-12 and gamma interferon (IFN-gamma) associated with widespread necrosis of the liver. Since costimulation is critical for T-cell activation, we investigated the role of the CD28-B7 and CD40-CD40 ligand (CD40L) interactions in this infection-induced immunopathology. Our studies show that infection of mice with T. gondii resulted in increased expression of B7 and CD40 that was similar in wild-type and IL-10KO mice. In vivo blockade of the CD28-B7 or CD40-CD40L interactions following infection of IL-10KO mice with T. gondii did not affect serum levels of IFN-gamma or IL-12, nor did it prevent death in these mice. However, when both pathways were blocked, the IL-10KO mice survived the acute phase of infection and had reduced serum levels of IFN-gamma and alanine transaminase as well as decreased expression of inducible nitric oxide synthase in the liver and spleen. Analysis of parasite-specific recall responses from infected IL-10KO mice revealed that blockade of the CD40-CD40L interaction had minimal effects on cytokine production, whereas blockade of the CD28-B7 interaction resulted in decreased production of IFN-gamma but not IL-12. Further reduction of IFN-gamma production was observed when both costimulatory pathways were blocked. Together, these results demonstrate that the CD28-B7 and CD40-CD40L interactions are involved in the development of infection-induced immunopathology in the absence of IL-10.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abatacept
  • Animals
  • Antigens, CD / biosynthesis
  • Antigens, CD / immunology*
  • Antigens, Differentiation / administration & dosage
  • Antigens, Differentiation / immunology
  • B7-1 Antigen / biosynthesis
  • B7-1 Antigen / immunology*
  • B7-2 Antigen
  • CD28 Antigens / immunology*
  • CD40 Antigens / biosynthesis
  • CD40 Antigens / immunology*
  • CD40 Ligand
  • CTLA-4 Antigen
  • Female
  • Immunoconjugates*
  • Interferon-gamma / biosynthesis
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology*
  • Interleukin-12 / biosynthesis
  • Membrane Glycoproteins / biosynthesis
  • Membrane Glycoproteins / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Knockout
  • Toxoplasma / immunology
  • Toxoplasmosis / immunology*
  • Toxoplasmosis / pathology

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • B7-1 Antigen
  • B7-2 Antigen
  • CD28 Antigens
  • CD40 Antigens
  • CTLA-4 Antigen
  • Cd86 protein, mouse
  • Ctla4 protein, mouse
  • Immunoconjugates
  • Membrane Glycoproteins
  • Interleukin-10
  • CD40 Ligand
  • Interleukin-12
  • Abatacept
  • Interferon-gamma